New Key Statistics Module, Z-Score and F-Score
NAS:JAGX Key Ratios
| Market Cap $ M | 9.61 |
| Enterprise Value $ M | 27.67 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.48 |
| Price/Sales | 0.09 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 10.00 |
| EPS (TTM) $ | -37.94 |
| Beneish M-Score | -2.8 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.85 |
| EV-to-EBITDA | -0.92 |
| PEG | -- |
| Shares Outstanding M | 9.24 |
| Net Margin (%) | -350.18 |
| Operating Margin % | -308.15 |
| Pre-tax Margin (%) | -355.51 |
| Quick Ratio | 1.60 |
| Current Ratio | 2.10 |
| ROA % (ttm) | -67.25 |
| ROE % (ttm) | -436.42 |
| ROIC % (ttm) | -86.02 |
| Dividend Yield % | -- |
| Altman Z-Score | -8.61 |
JAGX Number of Guru Trades
JAGX Volume of Guru Trades
Gurus Latest Trades with NAS:JAGX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:JAGX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Jaguar Health Inc Insider Transactions
No Available Data
News about NAS:JAGX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers